31.10.2014 Views

Cleveland Clinic Lerner Research Institute

Cleveland Clinic Lerner Research Institute

Cleveland Clinic Lerner Research Institute

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

22<br />

L e r n e r R e s e a r c h I n s t i t u t e<br />

The Fight Against Blindness<br />

Areas of research: inherited retinal diseases, glaucoma, macular<br />

degeneration, corneal repair and transplantation, retinal physiology,<br />

diabetic retinopathy, and vision restoration<br />

Recent Landmark Discoveries in Ophthalmic <strong>Research</strong><br />

• Identified oxidative protein modifications in ocular tissues and plasma that may contribute to age-related<br />

macular degeneration (AMD) and provide biomarkers of AMD risk and susceptibility<br />

• Generated an AMD-like phenotype in mice immunized with lipid-derived oxidative protein modifications<br />

• Prevented oxygen-induced retinopathy, similar to a retinal disease of severely premature infants, in a model<br />

using a drug that blocks the loss of hypoxia-inducible factor<br />

“We are mapping out the early events<br />

that may cause macular degeneration,<br />

the most common type of blindness in<br />

our aging population, which may lead<br />

to novel treatments.”<br />

Joe Hollyfield, PhD<br />

Cole Eye <strong>Institute</strong><br />

Vascularization of the eye<br />

Macular degeneration of the eye<br />

“Oxygen-induced retinopathy is characterized<br />

by an area of central blood vessel<br />

loss (arrow, top figure). We found that<br />

injection of human umbilical cord blood<br />

derived CD133+ progenitor cells rescued<br />

retinal damage by promoting repair of<br />

the vasculature (bottom figure).”<br />

Bela Anand-Apte, MBBS, PhD<br />

Cole Eye <strong>Institute</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!